Suppr超能文献

识别澳大利亚帕金森病患者住院期间药物错误的发生率和风险因素:一项为期 3 年的多中心研究。

Identifying rates and risk factors for medication errors during hospitalization in the Australian Parkinson's disease population: A 3-year, multi-center study.

机构信息

SA Pharmacy, SA Health, Adelaide, South Australia, Australia.

College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.

出版信息

PLoS One. 2022 May 4;17(5):e0267969. doi: 10.1371/journal.pone.0267969. eCollection 2022.

Abstract

BACKGROUND

Admission to hospital introduces risks for people with Parkinson's disease in maintaining continuity of their highly individualized medication regimens, which increases their risk of medication errors. This is of particular concern as omitted medications and irregular dosing can cause an immediate increase in an individual's symptoms as well as other adverse outcomes such as swallowing difficulties, aspiration pneumonia, frozen gait and even potentially fatal neuroleptic malignant type syndrome.

OBJECTIVE

To determine the occurrence and identify factors that contribute to Parkinson's medication errors in Australian hospitals.

METHODS

A retrospective discharge diagnosis code search identified all admissions for people with Parkinson's disease to three tertiary metropolitan hospitals in South Australia, Australia over a 3-year period. Of the 405 case notes reviewed 351 admissions met our inclusion criteria.

RESULTS

Medication prescribing (30.5%) and administration (85%) errors during admission were extremely common, with the most frequent errors related to administration of levodopa preparations (83%). A higher levodopa equivalent dosage, patients with a modified swallowing status or nil by mouth order during admission, and patients who did not have a pharmacist led medication history within 24 hours of admission had significantly higher rates of medication errors.

CONCLUSIONS

This study identified 3 major independent factors that increased the risk of errors during medication management for people with Parkinson's disease during hospitalization. Thus, targeting these areas for preventative interventions have the greatest chance of producing a clinically meaningful impact on the number of hospital medication errors occurring in the Parkinson's population.

摘要

背景

住院会给帕金森病患者带来风险,使他们难以维持高度个体化的药物治疗方案的连续性,从而增加药物错误的风险。这尤其令人担忧,因为漏服药物和不规则给药会导致个体症状立即加重,以及其他不良后果,如吞咽困难、吸入性肺炎、冻结步态,甚至可能致命的神经阻滞剂恶性综合征。

目的

确定澳大利亚医院帕金森病药物错误的发生情况,并确定导致药物错误的因素。

方法

通过回顾性出院诊断代码搜索,确定了在澳大利亚南澳大利亚州的三家三级大都市医院住院的所有帕金森病患者,时间跨度为 3 年。在审查的 405 份病历中,有 351 份符合我们的纳入标准。

结果

住院期间药物处方(30.5%)和给药(85%)错误极为常见,最常见的错误与左旋多巴制剂的给药有关(83%)。左旋多巴等效剂量较高、入院时吞咽功能改变或禁食、入院 24 小时内没有药剂师主导的药物史的患者,药物错误的发生率显著更高。

结论

本研究确定了 3 个主要的独立因素,这些因素增加了住院期间帕金森病患者药物管理中出现错误的风险。因此,针对这些领域进行预防干预,最有可能对帕金森病患者发生的医院药物错误数量产生有临床意义的影响。

相似文献

2
Assessment of appropriate medication administration for hospitalized patients with Parkinson's disease.评估住院帕金森病患者的合理药物治疗。
Parkinsonism Relat Disord. 2012 May;18(4):377-81. doi: 10.1016/j.parkreldis.2011.12.007. Epub 2012 Jan 9.
4
Medication errors in Parkinson's disease inpatients in the Basque Country.巴斯克地区帕金森病住院患者的用药错误
Parkinsonism Relat Disord. 2017 Mar;36:57-62. doi: 10.1016/j.parkreldis.2016.12.028. Epub 2016 Dec 31.

引用本文的文献

本文引用的文献

3
Drug-related problems in hospitalised Parkinson's disease patients in China.中国住院帕金森病患者的药物相关问题。
Eur J Hosp Pharm. 2022 Nov;29(6):308-312. doi: 10.1136/ejhpharm-2020-002356. Epub 2020 Oct 30.
10
Classification of advanced stages of Parkinson's disease: translation into stratified treatments.帕金森病晚期的分类:转化为分层治疗。
J Neural Transm (Vienna). 2017 Aug;124(8):1015-1027. doi: 10.1007/s00702-017-1707-x. Epub 2017 Mar 24.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验